Employee Wellbeing
With all that has taken place globally within the last
With all that has taken place globally within the last
It is supposed to be the most exciting time of
Health Care Spending Accounts (HCSA) A HCSA is a
The Mental Health IndexTM As Canadians head
Kate Bouey – Nov 16, 2017 / 5:00 am | Story: 211658 A rally will be held in Victoria Nov. 29 calling on the government to fund the drug Orkambi. A rally is to be held on the steps of the provincial legislature in Victoria later this month as two B.C. women ask for help […]
About 45,000 employees of Shoppers Drug Mart and parent company Loblaws based in Canada will have medical marijuana coverage as part of their work benefits, reports said. An internal memo released last week said this will cover a maximum of CAD$1,500 a year. Claims to insurance provider Manulife “will be considered only for prescriptions to […]
November 3, 2016 – News from Great West Life Effective immediately, plan members who use marijuana won’t automatically be considered smokers on insurance applications, unless they also use tobacco, e-cigarettes or nicotine products. This change applies to all coverage that requires medical underwriting. Great West Life has updated their Evidence of Insurability Coverage Detail form to reflect the […]
Effective June 1, 2016: The Ministry of Health is updating and expanding Pharmacare’s Reference Drug Program, with a focus on meeting the medical needs of patients. The Reference Drug Program is a part of Pharmacare, British Columbia’s public drug plan. The program groups certain types of drugs that treat the same illness or medical condition […]
There are several new drugs for cancer and rare diseases coming into the marketplace that fall into the “extremely expensive” category. That is because the pharma pricing model is imperfect and drug prices are difficult to control let alone predict both here and in the US. The reality is that drug plans were not designed […]
A low-cost treatment for hepatitis C could be available soon. CTVNews.ca Staff Published Monday, April 18, 2016 A non-profit group is working to develop an affordable treatment for hepatitis C that will cost less than US$300 per patient – a tiny fraction of the $80,000 price tag currently charged by big drug makers to treat […]